Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 200.20K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.20K | -- | -- | -- | -- |
| Cost of Revenue | 119.70K | -- | -- | -- | -- |
| Gross Profit | 80.50K | -- | -- | -- | -- |
| SG&A Expenses | 454.80K | 277.10K | 230.50K | 19.70K | 18.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 574.50K | 277.10K | 230.50K | 19.70K | 18.10K |
| Operating Income | -374.30K | -277.10K | -230.50K | -19.70K | -18.10K |
| Income Before Tax | -632.70K | -532.90K | -480.50K | -269.70K | -18.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.63 | -0.53 | -0.48 | -0.27 | -0.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -632.70K | -532.90K | -480.50K | -269.70K | -18.10K |
| EBIT | -374.30K | -277.10K | -230.50K | -19.70K | -18.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 520.73M | 510.47M | 510.47M | 510.00M | 510.00M |
| Average Diluted Shares Outstanding | 520.73M | 510.47M | 510.47M | 510.00M | 510.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |